Protein Flexibility and Dissociation Pathway Differentiation Can Explain Onset of Resistance Mutations in Kinases

Area of Science:

• Biophysics
• Computational Biology
• Pharmacology

Background:

• Drug resistance mutations pose a significant challenge in cancer therapy.
• Thermodynamic explanations for drug resistance are common, but some cases involve similar binding affinities with differing drug residence times.

Purpose of the Study:

• To elucidate the mechanistic basis for drug dissociation variances caused by protein mutations.
• To investigate the effect of the N368S mutation on the dissociation pathway of the anti-cancer drug Imatinib from Abl kinase.

Main Methods:

• Utilized all-atom molecular dynamics simulations.
• Applied recent advancements in statistical mechanics.
• Analyzed dissociation mechanisms of Imatinib against wild-type and N368S mutant Abl kinase.

Main Results:

• Identified distinct drug dissociation pathways for wild-type and mutant Abl kinase.
• Demonstrated that the N368S mutation significantly alters protein flexibility.
• Revealed a much faster drug dissociation pathway for the mutant protein.

Conclusions:

• All-atom molecular dynamics simulations provide mechanistic insight into drug resistance mutations.
• This approach offers an efficient and scalable method to understand resistance mechanisms not explained by structure alone.
• Findings contribute to understanding and potentially overcoming drug resistance in targeted cancer therapies.